Wang Zhang

发表

Ursolic acid reverses liver fibrosis by inhibiting NOX4/NLRP3 inflammasome pathways and bacterial dysbiosis

Xuan Zhu, Y. Nie, Qi Liu, 2021, Gut microbes.

Development and validation of a nomogram for predicting overall survival in cirrhotic patients with acute kidney injury

Xuan Zhu, An-jiang Wang, Hang Zhang, 2022, World journal of gastroenterology.

CSTF2 Acts as a Prognostic Marker Correlated with Immune Infiltration in Hepatocellular Carcinoma

Qi Liu, Yue Zhang, Xuan-jin Zhu, 2022, Cancer management and research.

CMAR_A_359545 2691..2709

Qi Liu, Yue Zhang, Xuan-jin Zhu, 2022 .

Ursolic acid ameliorates CCl4‐induced liver fibrosis through the NOXs/ROS pathway

Xuan Zhu, Jiang Chen, Chen-kai Huang, 2018, Journal of cellular physiology.

Ursolic acid alleviates Kupffer cells pyroptosis in liver fibrosis by the NOX2/NLRP3 inflammasome signaling pathway.

Qi Liu, Peng Chen, Chen-kai Huang, 2022, International immunopharmacology.

Development and validation of a prognostic nomogram for decompensated liver cirrhosis

Y. Nie, Qi Liu, Yue Zhang, 2022, World journal of clinical cases.

A bile acid-related prognostic signature in hepatocellular carcinoma

Qi Liu, Yue Zhang, Xuan-jin Zhu, 2022, Scientific Reports.

Longitudinal Metabolomics Reveals Ornithine Cycle Dysregulation Correlates With Inflammation and Coagulation in COVID-19 Severe Patients

Tao Li, Hui Wang, Z-h Wei, 2021, Frontiers in Microbiology.

Glaucocalyxin A attenuates carbon tetrachloride‐induced liver fibrosis and improves the associated gut microbiota imbalance

Xu-guang Hu, Wang Zhang, Qianwen Ma, 2023, Chemical biology & drug design.

Derivation and Validation of a Prognostic Model for Acute Decompensated Cirrhosis Patients

Yue Zhang, Chen-kai Huang, Xuan-jin Zhu, 2023, Patient preference and adherence.

Protective Effect of Ursolic Acid on the Intestinal Mucosal Barrier in a Rat Model of Liver Fibrosis

Xuan Zhu, Chen-kai Huang, J. Jian, 2019, Front. Physiol..